Skip to main content

Animations

MJFF Publications

7611 - 7620 of 8801 Results
Title
Year
  • Year
  • 2019
  • 2023
  • 2017
  • 2023
  • 2021
  • 2019
  • 2025
  • 2020
  • 2011
  • 2025
  • Summary Details
    OPEN
    Title: Lack of independent mood-enhancing effect for dopaminergic medications in early Parkinson's disease
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2019.05.009
    Citation Count: 6
  • Summary Details
    OPEN
    Title: MAPT allele and haplotype frequencies in Nigerian Africans: Population distribution and association with Parkinson's disease risk and age at onset
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105517
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learned
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.02.003
    Citation Count: 34
  • Summary Details
    OPEN
    Title: RTP801 mediates transneuronal toxicity in culture via extracellular vesicles
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/jev2.12378
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-021-85293-4
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Influence of analytic techniques on comparing DTI-derived measurements in early stage Parkinson's disease
    Journal Name: Heliyon
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.heliyon.2019.e01481
    Citation Count: 20
  • Summary Details
    RESTRICTED
    Title: Distinct neuronal vulnerability and metabolic dysfunctions are characteristic features of fast-progressing Alzheimer's patients with Lewy bodies
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jbc.2025.108396
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Differences in the Presentation and Progression of Parkinson's Disease by Sex
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28312
    Citation Count: 79
  • Summary Details
    RESTRICTED
    Title: AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(11)70039-4
    Citation Count: 655
  • Summary Details
    RESTRICTED
    Title: Lasmiditan ameliorates cortico-hippocampal pathology and improves cognition in aging parkinsonian mice
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2025.115502
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.